Chiara Riganti
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer, Hypoxia, and Metabolism 29
- Cancer, Lipids, and Metabolism 15
- Oncology 80
- Drug Transport and Resistance Mechanisms 50
- Co-authors
- Dario GhigoJoanna KopeckaElena GazzanoAmalia BosìaCostanzo CostamagnaElisabetta AldieriIris C. SalaroglioManuela Polimeni
- Journals
- International Journal of Molecular Sciences (11 papers)Journal of Medicinal Chemistry (10 papers)European Journal of Medicinal Chemistry (8 papers)Oncotarget (8 papers)Molecular Pharmaceutics (7 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Chiara Riganti
256 papers receiving 9.1k citations
Peers
Comparison fields: 5 of 154
- Cancer Research 2.0k
- Oncology 2.2k
- Biomaterials 995
- Molecular Biology 4.4k
- Immunology 1.2k
Countries citing papers authored by Chiara Riganti
This map shows the geographic impact of Chiara Riganti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Riganti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Riganti more than expected).
Fields of papers citing papers by Chiara Riganti
This network shows the impact of papers produced by Chiara Riganti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Riganti. The network helps show where Chiara Riganti may publish in the future.
Co-authors
The 25 scholars most cited alongside Chiara Riganti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 9 | |
| 4 | 2023 | 25 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 29 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 17 | |
| 13 | 2020 | 16 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 28 | |
| 16 | 2019 | 54 | |
| 17 | 2017 | 23 | |
| 18 | 2017 | 39 | |
| 19 | 2016 | 83 | |
| 20 | 2010 | 74 |
About Chiara Riganti
Chiara Riganti is a scholar working on Cancer Research, Oncology, Biomaterials, Molecular Biology and Biophysics, having authored 259 papers that have together received 9.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (50 papers), Nanoparticle-Based Drug Delivery (33 papers), Cancer, Hypoxia, and Metabolism (29 papers), Occupational and environmental lung diseases (24 papers), Cancer therapeutics and mechanisms (16 papers), Cancer, Lipids, and Metabolism (15 papers), Nitric Oxide and Endothelin Effects (14 papers) and Pharmacological Receptor Mechanisms and Effects (13 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (2.2k citations), Biomaterials (995 citations), Molecular Biology (4.4k citations) and Immunology (1.2k citations). Chiara Riganti has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Dario Ghigo, Joanna Kopecka, Elena Gazzano, Amalia Bosìa, Costanzo Costamagna, Elisabetta Aldieri, Iris C. Salaroglio, Manuela Polimeni, Ivana Campia and Gianpiero Pescarmona. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Oncotarget and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.